| Mrs Jodi Kathryn Flanagan, MPT | |
|
3950 17th St Ste B, Baker City, OR 97814-1300 | |
| (541) 523-8888 | |
| (541) 523-8889 |
| Full Name | Mrs Jodi Kathryn Flanagan |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 26 Years |
| Location | 3950 17th St Ste B, Baker City, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184632069 | NPI | - | NPPES |
| 803931003 | Other | OR | BC/BS OF OREGON |
| P00480330 | Other | OR | RAILRAOD MEDICARE |
| 181501 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 3687 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Robert J Bachman P T Pc | 4587551494 | 5 |
News Archive
Treating ovarian cancer with platinum-based chemotherapy drugs such as cisplatin is initially very effective, with about four out of five patients responding favorably. However, most of these patients quickly become resistant to chemotherapy and may not respond as well to this standard treatment for the disease.
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.
› Verified 8 days ago
| Provider Name | Robert J Bachman P T Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336274273 PECOS PAC ID: 4587551494 Enrollment ID: O20040303001092 |
News Archive
Treating ovarian cancer with platinum-based chemotherapy drugs such as cisplatin is initially very effective, with about four out of five patients responding favorably. However, most of these patients quickly become resistant to chemotherapy and may not respond as well to this standard treatment for the disease.
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jodi Kathryn Flanagan, MPT 3950 17th St Ste B, Baker City, OR 97814-1300 Ph: (541) 523-8888 | Mrs Jodi Kathryn Flanagan, MPT 3950 17th St Ste B, Baker City, OR 97814-1300 Ph: (541) 523-8888 |
News Archive
Treating ovarian cancer with platinum-based chemotherapy drugs such as cisplatin is initially very effective, with about four out of five patients responding favorably. However, most of these patients quickly become resistant to chemotherapy and may not respond as well to this standard treatment for the disease.
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.
Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.
› Verified 8 days ago
Mr. Thomas Leblanc, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3325 Poca Lontas Rd, St Elizabeth Health Service, Baker City, OR 97814 Phone: 541-523-8130 | |
Dr. Marshall Hiller, P.T., DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3950 17th St Ste B, Baker City, OR 97814 Phone: 541-523-8888 Fax: 541-523-8889 | |
Jerry Duane Nickell, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3325 Pocahontas Rd, Baker City, OR 97814 Phone: 541-523-8106 Fax: 541-523-8151 | |
Keith Harston, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3950 17th St Ste B, Baker City, OR 97814 Phone: 541-523-8888 | |
Anne Nemec, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1928 Court Ave, Baker City, OR 97814 Phone: 541-523-9664 Fax: 541-523-9665 | |
Kimberly Kay Zinn, D.P.T., ATC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3325 Pocahontas Rd, Baker City, OR 97814 Phone: 541-523-8130 |